People | September 05, 2024
Akums appoints Shantanu R Chobhe as Corporate Quality Assurance Head
Chobhe brings over 30 years of extensive experience in quality and regulatory management within the pharmaceutical industry
Chobhe brings over 30 years of extensive experience in quality and regulatory management within the pharmaceutical industry
Patni brings over 25 years of distinguished experience in the pharmaceutical industry
Dr. Roopal Thakkar joined Abbott/AbbVie in 2003 as part of the Physician Development Program
Dr. Jain is a biotechnology industry veteran with more than two decades of experience in pharmaceutical development across her time with ChemoCentryx, AbbVie, Abbott Laboratories, and G.D. Searle and Co
GlobalData predicts the average prices of dual chamber pacemakers in both India and China are expected to reduce at an average CAGR of -3.42% from 2022 to 2025.
The use of procalcitonin testing for sepsis management is highest in the US
The company has been ranked 8th on the list this year for three key attributes: ‘innovative leader in the industry’, ‘is socially responsible’ and ‘has loyal employees’
Abbott has recently received the US Food and Drug Administration nod to use its DBS device for treatment-resistant depression
A seasoned professional, he will lead the strategy and business operations of Cadila’s branded prescriptions pharma business
According to the brokerage, as the pandemic has receded, the past exceptional growth in acute therapies may not be repeated (stellar double-digit growth for anti-infectives coming down)
Subscribe To Our Newsletter & Stay Updated
